Uniting biotech and pharma scientists to revolutionize ophthalmic drug development, the Retinal Imaging Biomarkers and Endpoints Summit encourages forward-thinking discussions to enhance the adoption of novel imaging-based approaches to determine retinal function and optimize development of regulatory accepted endpoints.

Join 60+ retinal imaging, innovation, R and D, preclinical and clinical experts from the likes of Genentech, AbbVie, Apellis, Janssen and Novartis to overcome the translational challenges of choosing and implementing novel ophthalmic imaging biomarkers and endpoints in your research, to accelerate earlier, non-invasive and personalised healthcare for ophthalmic and neurodegenerative patients.

13 Jun - 15 Jun 2023, 9:00 am - 5:00 pm

Go to Event Website
Ticket pricing starts from:
Drug Developer Pricing - Conference + Workshop Day: USD 4297.00, Drug Developer Pricing - Conference Only: USD 2999.00, Standard Pricing - Conference + Workshop Day: USD 5297.00, Standard Pricing - Conference Only: USD 3799.00